Potentiel myogène vestibulaire oculaire évoqué chez les patients atteints de myasthénie grave: étude clinique prospecti

Verrouillé
Avatar du membre

Auteur du sujet
Pboulanger Prés.
Administrateur
Administrateur
Messages : 10762
Enregistré le : 02 févr. 2010 18:41
14
Localisation  : La Chapelle en Serval F-60520
Genre :
Zodiaque :
Âge : 67
    Windows 10 Firefox

Potentiel myogène vestibulaire oculaire évoqué chez les patients atteints de myasthénie grave: étude clinique prospecti

Message par Pboulanger Prés. »

:hi:

:arrow: Lu sur : https://www.ncbi.nlm.nih.gov/pubmed/28662779

[ligne][/ligne]

Traduction disponible directement en cliquant en bas à droite de ce message sur notre forum

Image

[ligne][/ligne]

Ocular vestibular evoked myogenic potential in patients with myasthenia gravis: A prospective clinical study.
El-Sayed Mojahed M1, Thabet EM2, El-Khateeb MG3, Elsayed Morgan A4.
Auris Nasus Larynx. 2017 Jun 26. pii: S0385-8146(17)30325-5. doi: 10.1016/j.anl.2017.06.001.


Abstract


  • OBJECTIVE:
    Myasthenia gravis (MG) is an archetypic disorder of neuromuscular junctions (NMJs) and autoantibody-mediated disease causing fatigable weakness of skeletal muscles with an ocular onset in up to 85%. The aim of this study was to detect extra ocular muscles (EOMs) abnormalities in MG patients using ocular vestibular evoked myogenic potential (oVEMP) n10 response.
  • METHODS:
    The oVEMP was performed on 40 myasthenia gravis patients that were divided into three groups: newly diagnosed (10 patients), uncontrolled on treatment (15 patients) and controlled on treatment (15 patients) groups in addition to a control group of 10 subjects. Also a comparison of oVEMP response was held between patients with generalized and ocular MG.
  • RESULTS:
    The oVEMP n10 showed significant difference between the 3 study groups and the control. The n10 showed no significant difference between the newly diagnosed group and the other 2 groups. There was also significant difference between uncontrolled and controlled on treatment group and between generalized and ocular types of myasthenic patients.
  • CONCLUSION:
    The oVEMP can be usefully used in diagnosis of new MG patients as regard n10 amplitude, threshold and AR except n10 latency with no therapeutic or monitoring value of oVEMP in MG.

Message d' un membre de l'équipe technique
Nous utilisons un service automatique de traduction fourni par YANDEX.
Soyez vigilant sur le risque de contre-sens inhérent à ce genre d'outils.
Amicalement,
Image
Verrouillé

Retourner vers « 2017 »